Results 311 to 320 of about 589,569 (384)

Soft Tissue Neoplasms

2017
Joana Pardal, Mai P. Hoang
openaire   +2 more sources

Undifferentiated and dedifferentiated soft tissue neoplasms: Immunohistochemical surrogates for differential diagnosis.

Seminars in diagnostic pathology, 2021
Undifferentiated soft tissue sarcomas (USTS) are described in the current World Health Organization Classification of Soft Tissue and Bone Tumours as those showing no identifiable line of differentiation when analyzed by presently available technologies.
K. Thway, C. Fisher
semanticscholar   +1 more source

Clinicopathological and molecular characterisation of USP6‐rearranged soft tissue neoplasms: the evidence of genetic relatedness indicates an expanding family with variable bone‐forming capacity

Histopathology, 2020
USP6 rearrangement underpins self‐limiting fibroblastic/myofibroblastic neoplasms, including nodular fasciitis (NF), myositis ossificans (MO), aneurysmal bone cyst (ABC), and related variants.
Jui‐Chu Wang, Wan-Shan Li, Yu-Chien Kao, Jen-Chieh Lee, Pei-Hang Lee, Shih-Chiang Huang, Jen‐Wei Tsai, Chien-Chin Chen, Ching-Di Chang, Shih‐Chen Yu, Hsuan-Ying Huang   +10 more
semanticscholar   +1 more source

PRAME Expression in Challenging Dermal Melanocytic Neoplasms and Soft Tissue Tumors With Melanocytic Differentiation

American journal of dermatopathology, 2022
: Preferentially expressed antigen in melanoma (PRAME) is an immunohistochemical biomarker that is diffusely expressed in most cutaneous melanomas and is negative in most benign nevi.
Nicholas J. Kline, Tyler D. Menge, S. Hrycaj, A. Andea, Rajiv M. Patel, P. Harms, M. Chan, S. Bresler   +7 more
semanticscholar   +1 more source

Targeted RNA sequencing: A routine ancillary technique in the diagnosis of bone and soft tissue neoplasms

Genes, Chromosomes and Cancer, 2018
The past decade has witnessed remarkable progress in delineating the molecular pathogenesis of many mesenchymal neoplasms. This, in large part, is attributable to the application of next‐generation sequencing.
B. Dickson, D. Swanson
semanticscholar   +1 more source

Paratesticular Soft Tissue Neoplasms

2016
Primary paratesticular soft tissue tumors are rare entities. Sarcomas have an estimated annual incidence of 0.3 cases per million [1] and represent 7–10 % of intrascrotal tumors [2]. However, among genitourinary sarcomas, the paratesticular region is the most commonly involved site [3]. They usually affect adult patients, with a median age at diagnosis
Franchi, Alessandro, Santi, Raffaella, Nesi, Gabriella   +2 more
openaire   +2 more sources

Neoplasm of Soft Tissues

2014
Soft tissue sarcomas represent a diverse group of rare neoplasms. Strong evidence supports a causal role for soft tissue sarcomas of TCDD and TCDD-contaminated agents. Among suspected agents are ionizing radiation and vinyl chloride.
Franco Merletti, Emanuela Ciliberto, Dario Mirabelli   +2 more
openaire   +1 more source

Myxoid soft-tissue neoplasms

2019
Learning objectives Background Findings and procedure details Conclusion Personal information ...
openaire   +1 more source

Imaging of pedal soft tissue neoplasms

The Journal of Foot and Ankle Surgery, 1995
The authors discuss various radiographic imaging techniques for pedal soft tissue lesions. These include xeroradiography, angiography, ultrasound, computed tomography, and magnetic resonance imaging. Illustrative cases of each modality, as well as an evaluation of advantages and disadvantages, are presented.
D S, Levey, Y H, Park, D J, Sartoris
openaire   +2 more sources

Paratesticular soft tissue neoplasms.

Seminars in diagnostic pathology, 2001
Paratesticular soft tissue tumors are uncommon neoplasms that may present significant challenges for the pathologist and clinician. This article reviews the incidence of these rare tumors, and on the common benign and malignant entities that occur in this location. Key points in differential diagnosis are emphasized.
A L, Folpe, S W, Weiss
openaire   +1 more source